2026-2027 Seminar Series
| Date | Time/Location | Speaker/Topic |
|---|---|---|
| Wed, January 21, 2026 | 9:00-10:00 AM | Kelly Stevens, PhD University of Washington Bioprinting Human Liver |
| Wed, March 18, 2026 | 9:00-10:00 AM | Alan Mullen, MD, PhD UMass Chan Medical School Modeling and Modulating Hepatic Stellate Cells to Develop Approaches to Inhibit Liver Fibrosis |
| Wed, May 20, 2026 | 9:00-10:00 AM | Cholsoon Jang, PhD UC Irvine Metabolic Mechanisms of Liver Cancer and Alcohol-Induced Toxic Protein Modification |
| Wed, June 17, 2026 | 9:00-10:00 AM | Jeffrey Schwimmer, MD UCSD Early-Life Steatotic Liver Disease: Lessons From Metabolic Mechanisms of Liver Cancer and Alcohol-Induced Toxic Protein Modification |
| Wed, Sept 30, 2026 | 9:00-10:00 AM | Zhenghui Jiang, MD, PhD Beth Israel Deaconess Medical Center |
| Wed, Nov 18, 2026 | 9:00-10:00 AM | Arash Grakoui, PhD Emory University |
| Wed, Jan 20, 2027 | 9:00-10:00 AM | Kari Nejak-Bowen, MBA, PhD University of Pittsburgh |
| Wed, Feb, 17, 2027 | 9:00-10:00 AM | Samar Ibrahim, M.B., Ch.B. Mayo Clinic |
| Wed, Mar, 17, 2027 | 9:00-10:00 AM | Valerie Gouon-Evans, PhD Boston University |
| Wed, May, 19, 2027 | 9:00-10:00 AM | Frank Anania, MD FDA |
| Wed, June, 16, 2027 | 9:00-10:00 AM | Mark Yarchoan, MD John Hopkins |